22nd International Conference on AIDS and STIs in Africa (ICASA 2023)

December 4–9, 2023

Harare, Zimbabwe

Event Website

Council staff will participate virtually in several activities at ICASA 2023. The Population Council Center for Biomedical Research will have posters displayed in the poster exhibition hall to share our work on the REACH (MTN-034) study, PrEP stigma associated with adolescent girls and young women, and a digital chatbot to assess risk and prevention amongst ciswomen and transgender men.


Sessions & Speakers

  1. Sunday 12/03

      Pre-conference | 10:00 am - 3:00 pm |

      Biomedical HIV Prevention Forum (BHPF)

      BHPF, a pre-conference of the 22nd ICASA Conference, puts HIV prevention research on the spotlight by providing a unique platform where participants gather to learn about progress made and best practices in biomedical HIV prevention research and development. BHPF pre-conference that brings together diverse stakeholders, HIV prevention advocates, civil society representatives, researchers, government officials, and frontline providers.


      Coordinated by Africa free of New HIV infections (AfNHi)  an African regional advocacy network dedicated to advancing, advocacy, policy, regulatory, community engagement and communications efforts that help accelerate biomedical HIV prevention research in Africa. IPM South Africa has been BHPF partner having contributed financially of the pre-conference. This year’s BHPF pre-conference Sinazo Pato, Community Engagement & Partnership Manager will be co-moderating the proceedings. To participate, register to attend in person or virtually: https://afnhi.org/bhpf-2023/

    • Monday 12/04

      Satellite | 12:25 PM - 1:10 PM | Sapphire

      AVAC: Shaping the future of choice in prevention: Gearing up for the rollout of the Dual Prevention Pill, the newest MPT in the toolbox
      Offering choice in products and programs is paramount to improving SRH and ultimately ending the HIV epidemic, as end users have diverse, dynamic preferences and needs that cannot be addressed by a single intervention. Expanding the toolbox of biomedical prevention options by bringing multipurpose prevention technologies (MPTs) to market will broaden choice and help to integrate PrEP within broader SRH programs and services. As the next MPT on the horizon, the Dual Prevention Pill (DPP) offers an additional option to address the persistent HIV epidemic and unmet need for family planning among women and girls in sub-Saharan Africa. This satellite session will share the latest learnings from the DPP Consortium, a coalition of organizations preparing for the introduction of the DPP in Zimbabwe, South Africa and Kenya.

    • Wednesday 12/06

        Poster | All day | Virtual poster exhibition

        Higher Acceptability of the Monthly Dapivirine Ring Versus Daily Oral PrEP among AGYW in sub-Saharan Africa in REACH (MTN-034/IPM 045)

        Barbara A. Friedland, Erica Browne, Sarah T. Roberts, Kenneth Ngure, Danny Szydlo, Rita Nakalega, Sherri Johnson, Tara McClure, Pippa Macdonald, Cynthia Nombeko Mpongo, Siyanda Tenza, Nomsa Mhlanga, Gonasagrie Nair, Connie Celum, Sharon L. Hillier, and Ariane van der Straten13 on behalf of the MTN-034/IPM-045 REACH clinical trial team

      • Friday 12/08

          Poster | All day | Virtual poster exhibition

          Role of Stigma in PrEP Use among Adolescent Girls and Young Women in Southern and East Africa: Framework for action (FRPED037)

          Waimar Tun, Lulama Lunika, Karen Kirk, Sanyukta Mathur


          Let’s Chat! A digital chatbot tool for self-assessing HIV risk and prevention for cisgender women and transgender men in Nigeria (FRPEE030)

          Waimar Tun, Anita Eromhonsele, Adebola Adedimeji, Zachary Vallarino, Craig Savel, Edward Oche, Olisa Ononye, Elizabeth Shoyemi, Sanyukta Mathur

        Go to Top